Close
London & Seoul: tuberculosis patient cohorts to understand treatment response
Project Summary
Each year, 9 million people are infected with a Mycobacterium tuberculosis infection globally. TB causes about 1.5 million deaths per year which is more than any other infectious disease.
The treatment of TB is complex and takes long. Even treatment of drug-sensitive disease generally lasts for six months. Efforts to shorten regimens have proved unpromising and treatment outcome of TB also remains difficult to predict. Even though such predictions could support research and development focused on treatment shortening and personalisation.
This partnership award will undertake the groundwork for future TB patient cohorts in London and Seoul through capacity building.
Key Project Information
Dates: 01/05/2019 - 31/07/2021
Status: Completed
UCL lead/Principal Investigator: Frank Kloprogge
Partners: The Catholic University of Korea/Incheon St. Mary's Hospital, Republic of Korea & Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, United Kingdom.
Location: UK and Republic of Korea
Funding: MRC
Contact: f.kloprogge@ucl.ac.uk
- Research Team
Frank Kloprogge
Jusang Kim
Timothy McHugh
Hyung Woo Kim
Jinsoo Min
Marc Lipman
Rishi Gupta
Mahdad Noursadeghi
Helen Stagg